Smruthi Organics Reports Q3 FY26 Results Following Board Meeting Approval

3 min read     Updated on 16 Feb 2026, 11:26 AM
scanx
Reviewed by
Jubin VScanX News Team
Overview

Smruthi Organics Limited reported Q3 FY26 financial results following Board approval on February 13, 2026. While quarterly net profit declined to ₹139.79 lakhs from ₹148.07 lakhs year-on-year, nine-month performance showed strong growth with 77% increase in net profit to ₹235.87 lakhs. The company recognized an exceptional expense of ₹45.17 lakhs due to new Labour Codes implementation.

32509646

*this image is generated using AI for illustrative purposes only.

Smruthi Organics Limited has announced its unaudited financial results for the third quarter ended December 31, 2025, following approval by the Board of Directors at a meeting held on February 13, 2026. The pharmaceutical company, specializing in bulk drugs and drug intermediates, submitted these results under Regulation 33 of SEBI Listing Obligations and Disclosure Requirements Regulations, 2015.

Board Meeting and Regulatory Compliance

The Board meeting commenced at 10:30 am and concluded at 11:15 am on February 13, 2026. The company submitted the unaudited financial results along with a Limited Review Report issued by statutory auditors Gokhale & Sathe, Chartered Accountants. The results have been made available on the company's website at www.smruthiorganics.com .

Meeting Details: Information
Date: February 13, 2026
Duration: 10:30 am to 11:15 am
Auditors: Gokhale & Sathe, Chartered Accountants
Regulation: SEBI Regulation 33

Financial Performance Overview

The company's financial performance for Q3 FY26 presents mixed quarterly results but demonstrates strong nine-month growth across key metrics.

Metric: Q3 FY26 Q3 FY25 Change Nine Months FY26 Nine Months FY25 Change
Revenue from Operations: ₹2229.11 lakhs ₹3124.97 lakhs -28.70% ₹7287.84 lakhs ₹8791.34 lakhs -17.10%
Net Profit: ₹139.79 lakhs ₹148.07 lakhs -5.60% ₹235.87 lakhs ₹133.28 lakhs +77.00%
Earnings Per Share: ₹1.22 ₹1.29 -5.40% ₹2.06 ₹1.16 +77.60%

Quarterly Results Analysis

For the third quarter of FY26, Smruthi Organics reported revenue from operations of ₹2229.11 lakhs, representing a decline from ₹3124.97 lakhs in the corresponding quarter of the previous year. Despite the revenue decline, the company maintained profitability with a net profit of ₹139.79 lakhs for the quarter, though this was lower than the ₹148.07 lakhs achieved in Q3 FY25.

Nine-Month Performance Highlights

The nine-month performance demonstrates remarkable improvement, with net profit showing growth of 77.00% to ₹235.87 lakhs from ₹133.28 lakhs in the corresponding period of the previous year. This strong performance resulted in earnings per share of ₹2.06 for the nine-month period, significantly higher than ₹1.16 in the previous year.

Segment Performance

The company operates primarily in two segments - API (Active Pharmaceutical Ingredients) and Formulations.

Segment: Q3 FY26 Revenue Q3 FY25 Revenue Nine Months FY26 Nine Months FY25
API: ₹2225.95 lakhs ₹3119.84 lakhs ₹7271.68 lakhs ₹8762.36 lakhs
Formulation: -₹0.56 lakhs ₹5.15 lakhs ₹20.92 lakhs ₹29.44 lakhs

The API segment remains the primary revenue driver, though it experienced a decline in the current quarter. The formulation division reported a loss of ₹32.21 lakhs for the nine-month period.

Impact of New Labour Codes

A significant development during the quarter was the implementation of India's New Labour Codes effective November 21, 2025. The company recognized an exceptional expense of ₹45.17 lakhs towards gratuity due to changes in the definition of wages under the new framework. This impact has been treated as an exceptional item in the financial statements.

Key Financial Metrics

Financial Parameter: Q3 FY26 Q3 FY25
Cost of Materials Consumed: ₹1001.54 lakhs ₹1550.04 lakhs
Employee Benefit Expenses: ₹453.98 lakhs ₹443.19 lakhs
Finance Costs: ₹25.25 lakhs ₹50.84 lakhs
Paid-up Capital: ₹1144.63 lakhs ₹1144.63 lakhs

The results were reviewed by the Audit Committee and approved by the Board of Directors, with statutory auditors conducting a limited review of the unaudited financial results.

Historical Stock Returns for Smruthi Organics

1 Day5 Days1 Month6 Months1 Year5 Years
-0.81%-6.55%-0.89%-21.27%+0.43%-54.08%

Smruthi Organics Limited Schedules Board Meeting on February 13, 2026 for Q3FY26 Results Approval

1 min read     Updated on 05 Feb 2026, 12:19 PM
scanx
Reviewed by
Jubin VScanX News Team
Overview

Smruthi Organics Limited has scheduled a board meeting on February 13, 2026, to approve unaudited financial results for Q3FY26 ended December 31, 2025. The company notified BSE Limited and Metropolitan Stock Exchange of India Ltd under SEBI Regulation 29. The trading window, closed since January 1, 2026, will remain restricted until 48 hours after the financial results declaration.

31819770

*this image is generated using AI for illustrative purposes only.

Smruthi Organics Limited has scheduled a board meeting for February 13, 2026, to approve its unaudited financial results for the third quarter of fiscal year 2026. The company formally notified stock exchanges about this upcoming board meeting through an official communication dated February 5, 2026.

Board Meeting Details

The meeting has been convened in compliance with regulatory requirements and will focus on approving quarterly financial performance. The company has provided specific details about the meeting's agenda and timeline to ensure transparency with stakeholders.

Parameter: Details
Meeting Date: February 13, 2026
Quarter Period: Third quarter ended December 31, 2025
Financial Standards: Indian Accounting Standards (Ind AS)
Regulation: SEBI (LODR) Regulations, 2015 - Regulation 29

Stock Exchange Notifications

Smruthi Organics Limited has formally communicated with multiple stock exchanges regarding the board meeting. The company submitted notifications to BSE Limited at P. J. Tower, Dalal Street, Mumbai, and Metropolitan Stock Exchange of India Ltd at Piramal Agastya Corporate Park, Kurla West, Mumbai. These notifications ensure compliance with listing obligations and maintain transparency with regulatory authorities.

Trading Window Restrictions

The company has implemented trading window restrictions in accordance with insider trading regulations. The trading window closure affects company insiders and designated persons who have access to unpublished price-sensitive information.

Restriction Details: Timeline
Window Closure Start: January 1, 2026
Closure Duration: Until 48 hours after results declaration
Previous Intimation: December 29, 2025
Results Period: Third Quarter ended December 31, 2025

Regulatory Compliance

The board meeting announcement demonstrates Smruthi Organics Limited's adherence to SEBI regulations governing listed companies. Under Regulation 29(1) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, companies must inform stock exchanges about board meetings where financial results will be considered. This advance notice allows market participants to prepare for the upcoming financial disclosure and ensures orderly market functioning.

The company secretary and compliance officer, Urvashi D. Khanna, signed the official communication, emphasizing the formal nature of this regulatory filing. The notification maintains the company's commitment to transparent corporate governance and timely disclosure of material information to stakeholders.

Historical Stock Returns for Smruthi Organics

1 Day5 Days1 Month6 Months1 Year5 Years
-0.81%-6.55%-0.89%-21.27%+0.43%-54.08%

More News on Smruthi Organics

1 Year Returns:+0.43%